期刊文献+

亚胺培南-EDTA纸片增效法检测非发酵菌的金属β-内酰胺酶 被引量:3

Detection of metallo-β-lactamase produced from non-fermenting bacilli by using imipenem-EDTA disk method
下载PDF
导出
摘要 目的为了解临床分离的非发酵菌(NFB)产金属β-内酰胺酶(MBL)阳性率。方法采用MH琼脂扩散法,以加与不加EDTA亚胺培南纸片的抑菌环直径差异确定MBL的产生。结果484株待测NFB菌株中,MBL阳性率分别是:嗜麦芽窄食单胞菌为100.0%、铜绿假单胞菌为49.0%、洋葱伯克霍尔德菌为63.9%、鲍曼不动杆菌为7.5%、脑膜败血黄杆菌为94.1%、产吲哚黄杆菌为80.9%、少动鞘胺醇单胞菌为13.3%。结论临床分离的NFB存在较高的MBL阳性率,应采取有效措施防止产MBL菌的进一步扩散。 Objective To study the prevalence of metallo-β-lactamase(MBL) produced from non-fermenting bacilli(NFB) separated from clinical specimens. Methods The MBL-producers were detected by comparing the inhibition zones using imipenem containing EDTA or not in the MH agar. Results Among 484 tested strains of NFB, the MBL-producing strains were 100.0% in S.maltophilia, and with 49.0% of P.aeruginosa, 63.9% of B.cepacia, 7.5% of A.bauamanii, 94.1% of F.meningosepticum, 80.9% of F.indologenes, 13.3% of S. paucimobilis, respectively. Conclusions The NFB isolated from clinical specimens present a higher MBL-producing prevalence, so an efficient measures should be taken to prevente further spread of MBL-producing NFB.
出处 《江西医学检验》 2005年第2期109-110,共2页 Jiangxi Journal of Medical Laboratory Sciences
  • 相关文献

参考文献5

  • 1朱琴,彭少华,李从荣,李艳.产金属β-内酰胺酶铜绿假单胞菌的协同试验方法研究[J].中华医院感染学杂志,2003,13(10):969-971. 被引量:39
  • 2Yong D,Lee K,Yum JH,et al. Imipenem-EDTA disk method for differentiation of metallo-β-lactamase-producing clinical isolates of Pseudomonas spp and Acinetobacter spp[J]. J Clin Microbiol,40(10):3798~3801.
  • 3顾剑,彭少华,李从荣.获得性金属β-内酰胺酶初筛方法的研究[J].中华医院感染学杂志,2004,14(6):603-606. 被引量:25
  • 4Poriel L, Nass T, Nicolas D, et al. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and intergron-bornr gene from a Pseudomonas aeruginosa clinical isolates in France[J]. Antimicrob Agents Chemother.2000,44(4):891 ~897.
  • 5Lee K,Chong Y,Shin HB, et al. Modified hodge and EDTA-disk synergy tests to screen metallo-β-lactamase-producing isolates of Pseudomonas and Acinetobacter species [J]. Clin Microbiol Infect,2001,7(2):88~91.

二级参考文献15

  • 1Woodford N, Palepou MF, Babini GS, et al . Carbapenemaseproducing Pseudomonas aeruginosa in UK[J]. Lancet, 1998,352: 546-547.
  • 2Arskawa Y, Shibata N, Shibayama K, et al . Convenient test for screening metallo-beta-lactamase-producing Gram-negative bacteria by using thiol compounds[J]. J Clin Microbiol, 2000, 38 : 40-43.
  • 3Senda K, Arakawa Y, Ichiyama S, et al . PCR detection of metallo-beta-lactamase gene (blaIMP) in Gram-negative rods resistant to broad-spectrum-beta-lactams[J]. J Clin Microbiol, 1996, 34: 2909-2913.
  • 4Riccio ML, Franceschini N, Boschi L, et al . Characterization of the metal β-lactamase determinant of Acinetobacter baumannii AC-54/97 reveals the existence of blaIMP allelic variants carried by gene cassettes of different phylogeny[J]. Antimicrob Agents Chemother, 2000, 44: 1229-1235.
  • 5Iyobe S, Kusadokoro H, Ozaki G, et al. Acid substitutions in a variant of IMP-1 metallo-β-lactamase[J]. Antimicrob Agents Cbemotber, 2000, 44: 2023-2027.
  • 6Peter MH, Xiong JH, Ye HC, et al . Occurrence of a new metallo-β-lactamase IMP-4 carried on a conjugative plasmid in Citrobacter youngae from the People's Republic of China[J]. FEMS Microb Lett, 2001, 194: 53-57.
  • 7Riccio ML, Pallecchi L, Fontana R, et al. In 70 of plasmid pAX22, a bla(VIM-1)-containing integron carrying a new aminoglycoside phosphotransferase gene cassette[J]. Antimicrob Agents Chemother, 2001, 45z 1249-1253.
  • 8Pirel L, Naas T, Nicolas D, et al. Characterization of VIM-2, ametallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France[J]. Antimicrob Agents Chemother, 2000, 44: 891-897.
  • 9Yan JJ, Hsueh PR, Ko WC, a al. Metallo-β-lactamases in clinical isolates in Taiwan and identification of VIM-3 a novel variant of VIM-2 enzyme [J]. Antimicrob Agents Chemother,2001, 45: 2224-2228.
  • 10Lauretti L, Riccio ML, Mazzariol A, et al. Cloning and characterization of blaVIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate[J]. Antimicrob Agents Chemother, 1999, 43(7): 1584-1590.

共引文献59

同被引文献38

  • 1[1]National committee for clinical laboratory standards.Performance standards for antimicrobial susceptibility testing[S].M100-S14,2004.
  • 2[3]Patzer J,Toleman MA,Deshpande LM,et al.Pseudomonas aerugi-nosa strains harbouring an unusual bla VIM-4 gene cassette isolated from hospitalized children in Poland(1998-2001)[J].J Antimicrob Chemother,2004,53(3):451~456.
  • 3[4]Pagani L,Mantengoli E,Lopes M,et al.Molecular analysis of met-allo-beta-lactamase gene bla(SPM-1)-surrounding sequences from disseminated Pseudomanas aeruginosa isolates in Recife[J].Brazil,Antimicrob Agents Chemother,2004,48(4):1406~1409.
  • 4[5]Masuda N,Sakagawa E,Ohya ST,et al.Hypersusceptibility of the Pseudomonas aeruginosa nfxB Mutant to β-Lactamase due to re-duced expression of the AmpC B-Lactamase[J].Antimicrob Agents Chemother,2001,45(4):1284~1286.
  • 5Bush K,Jacoby G A,Medeirous A A.A functional classification scheme for β-lactamase and its correlation with molecular structure[J].Antimicrob Agents chemother,1995,39(4):1211
  • 6Watanabe M,Lyobe S,Inoue M,et al.Transferable imipenem resistance in Pseudomonas aeruginosa[J].Antimicrob Agents Chemother,1991,35:127
  • 7Rasmussen B A,Bush K.Carbapenem-hydrolyzing betalactamases[J].Antimicrob Agents Chemother,1997,41(2):223
  • 8Ambler R P.The structure of beta-lactamases[J].Philos Trama R Soc London B Biol Sci,1980,289(1036):321
  • 9Wang Z,Fast W,Benkovic S J.On the mechanism of the metallo-beta-lactamase from Bacteroides fragilis[J].Biochemistry,1999,38(31):10013
  • 10Philippon A,Dusart J,Joris B,et al.The diversity structure and regulation of beta-lactamases[J].Cell Mol Life Sci,1998,54(6):341

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部